Here's how this #BayArea #biotech is looking to change #diabetes treatments. bizjournals.com/sanfrancisco/n…

Thanks FORTUNE for sharing! #BayArea #ucsf #startup Crystal Nyitray SVLC Khosla Ventures Read Fortune's Term Sheet content.fortune.com/newsletter/ter…

Expansions & Launches FDB (First Databank Inc.) launches clinical decision support #Analytics solution MindPath Care Centers & @CPsychMD announce expansion of #MentalHealth services in #Texas Encellin, a #regenerativemedicine company are developing implanted cell pouches to treat #chronicdisease

.Encellin CEO Crystal Nyitray highlights the biotech company's innovative approach to delivering cell therapy to treat chronic diseases medcitynews.com/2021/08/person… #biotech #regenerativemedicine #chronicdisease #startups

QB3 alum Crystal Nyitray is @RosenmanInst's #Healthtech Leader of the Month. CEO & co-founder of Encellin, developing cell encapsulation devices to treat chronic diseases incl. endocrine disorders rosenmaninstitute.org/healthtech-lea… @TejalDesaiUCSF The Desai Lab @ UCSF UC San Francisco

Thanks BioSpace Demy Colton for letting Encellin share our vision for the future! #startups #JPMorgan #BiotechShowcase biospace.com/article/cardio…

Encellin pouches $9.9m to target diabetes with cell encapsulation tech Khosla Ventures and Y Combinator back UCSF spinout developing implantable pouches that release therapeutic cells when needed. Encellin #investment #diabetes #celltherapy longevity.technology/news/encellin-…

Pleased to announce our $9.9M financing led by Khosla Ventures to advance our Encapsulated Cell Replacement Therapy (EnCRT)!! 🎉 🎉 🎉 Grateful for the support of our investors and incredible dedication of Encellin team.

Thanks Endpoints News for speaking about Encellin about our recent financing and vision for the future of living medicine!

Grateful for the continued support of Y Combinator to help Encellin advance medicine!

.Encellin announced today that it closed a $9.9M #financing round to support its cell encapsulation platform. The company develops an encapsulated cell replacement therapy (#EnCRT). MORE HERE: drugdeliverybusiness.com/encellin-finan… #diabetes #finance #TherapeuticCells #ImmuneSystem

Thanks Y Combinator for sharing in this journey!!

Congratulations Encellin @AmerDiabetesAssn Health Tech Showcase Winner 2017 #UCSFProud UC San Francisco UCSF School of Pharmacy UCSF School of Medicine Graduate Education and Postdoctoral Affairs

And the winner is ... Encellin! Thank you to the judges: Barbara Greenspan (Intel), Linda Elkins (Gore), & Brad Vale #stopdiabetes

Heard on "All Things Considered." Implant-Type 1 Diabetes Congrats🥂 @Encellin UC San Francisco UCSF School of Pharmacy UCSF School of Medicine npr.org/sections/healt…

Encellin is Developing a Cell Therapy Technology to Address Type I Diabetes mdgdgt.com/2hUifqe